Separate Tissue Product/Transplant Laws Requested To Reduce EU Reg Onus
This article was originally published in The Gray Sheet
Executive Summary
Investment in European tissue-engineered medical devices will suffer if the European Parliament's report on a proposed directive for human tissue quality and safety standards is not amended, EU stakeholders say